Published in TB and Outbreaks Week, January 7th, 2003
This agreement contemplates the issuance of 150,000 common shares with an additional 2 warrants for each share purchased at an exercise price of $1.50 for a 2-year period. This agreement is subject to applicable securities laws and approval by the TSX Venture Exchange.
AHD is also MedMira's exclusive distributor in the United States, and has previously ordered 500,000 Reveal Rapid HIV-1 Antibody Tests to be delivered following receipt of premarket approval by the United States Food and Drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.